Canadian buyers ought to contemplate proudly owning high quality progress shares which have the potential to ship market-beating returns over time. On this article, I’ve recognized three prime Canadian shares that would doubtlessly flip $10,000 into $100,000 throughout the subsequent decade.

Canadian inventory #1

Valued at $220 million by market cap, Profound Medical (TSX:PRN) operates as a commercial-stage medical gadget firm that develops and markets incision-free therapeutic programs for the image-guided ablation of diseased tissue in Canada, Germany, the USA, and Finland.

Profound Medical reported Q2 outcomes that fell in need of expectations, with income of $2.2 million remaining flat in comparison with the prior yr. The corporate reported a internet lack of $15.7 million, or $0.52 per share, wider than the $6.9 million loss it incurred in the identical interval a yr earlier. Working bills elevated to $15.4 million from $9.3 million as the corporate invested in its industrial growth.

Regardless of reporting sluggish gross sales in Q2, administration maintained its steerage for full-year progress of 70% to 75%. The corporate has 80 certified leads in its gross sales pipeline, with 14 presently within the contracting stage. Profound now operates 60 energetic websites and expects to achieve not less than 75 by the tip of the yr.

Key milestones

Two main milestones had been achieved throughout the quarter. The CAPTAIN medical trial has accomplished enrollment with 212 sufferers, exceeding the unique goal of 201 sufferers. Preliminary outcomes confirmed that TULSA sufferers skilled no blood loss, no in a single day hospital stays, and considerably much less ache in comparison with sufferers present process robotic surgical procedure.

The corporate additionally launched its TULSA-AI quantity discount software program for treating benign prostatic hyperplasia. The brand new module reduces process instances to 60–90 minutes no matter prostate dimension, making it aggressive with different BPH therapy choices. Full CAPTAIN outcomes might be offered in December at main medical conferences.

Analysts monitoring the TSX inventory forecast free money circulation to extend to $63 million in 2028, in comparison with an outflow of $32.5 million in 2025.

If PRN inventory is priced at 20 instances ahead free money circulation, it might acquire roughly 475% throughout the subsequent three years.

Canadian inventory #2

A pre-revenue firm, Poet Applied sciences (TSXV:PTK) designs, develops, manufactures, and sells semiconductor services and products for industrial purposes in the USA, Canada, Singapore, and China. It gives photonic built-in packaging options primarily based on the POET Optical Interposer. This platform permits the seamless integration of digital and photonic gadgets onto a single chip utilizing superior wafer-level semiconductor manufacturing methods.

In Q2 2025, Poet posted income of $268,469, up from zero within the prior yr interval however nonetheless reflecting restricted industrial gross sales. The quarter resulted in a internet lack of $17.3 million, or $0.21 per share, in comparison with a internet lack of $8 million in the identical quarter a yr earlier.

The broader loss stemmed largely from a $7.5 million non-cash cost associated to warrant revaluations. Analysis and growth spending reached $3.2 million, up from $2.1 million within the prior yr, as the corporate transitioned from know-how growth to product commercialization.

Manufacturing progress

Notably, POET accomplished set up of all manufacturing gear at Globetronics and expanded capability by partnering with NationGate Options in Malaysia for mild supply manufacturing.

POET added Lessengers as a buyer for 800G optical engine modules and closed a $30 million fairness financing at $5.00 per share, its most important single elevate.

Administration expressed confidence in assembly progress targets as buyer engagements intensify and manufacturing services endure qualification. Analysts monitoring the Canadian inventory forecast gross sales to rise to $141 million in 2027, up from lower than $2 million in 2025.

Canadian inventory #3

The ultimate Canadian inventory on the record is Excessive Tide Prescription drugs (TSXV:HITI), which is engaged within the hashish retail enterprise. It sells merchandise via a community of retail shops, a wholesale distribution arm, and its e-commerce platform.

Analysts monitoring the hashish inventory forecast income to extend from $522.3 million in fiscal 2024 (led to October) to $1.1 billion in fiscal 2029. Its adjusted earnings per share are forecast to broaden to $0.64 in 2029, in comparison with a loss per share of $0.04 per share in 2025.

If HITI inventory is priced at 25 instances ahead earnings, it might greater than triple throughout the subsequent three years.